Literature DB >> 10364026

Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time.

B Moum1, A Ekbom, M H Vatn, K Elgjo.   

Abstract

OBJECTIVE: Colonoscopy has replaced barium enema as the method for determining the extent of disease in patients with ulcerative colitis (UC). Normally, the extent of disease is determined by direct visualization of the mucosa, but biopsies are also used with increasing frequency. Very little is known about the extent to which these two ways of assessing the extent of disease are correlated and whether the correlation differs over time. The aim of this study was to determine the changes in extent of disease assessed by direct visualization and by histological examination of the mucosa at the time of diagnosis and after 1 yr of follow-up in a cohort of incident cases of UC patients.
METHODS: All new cases of UC in a defined population were identified during a 4-yr period (496 patients). Of these, 384 patients (78%) were available for follow-up and were subjected to a second colonoscopy with representative biopsies taken from both normal and affected mucosa.
RESULTS: After 1 yr there were macroscopical signs of progression in 14%; 22% showed regression, and 30% had a normal colonoscopy. The histological changes from diagnosis until follow-up showed progression in 20%, 24% showed regression, and 24% had normal histological findings. Histological examination showed more extensive disease than did direct visualization in 4% of patients at diagnosis and in 28% at follow-up, whereas direct visualization showed more extensive disease than did histological examination in 18% of patients at diagnosis and 12% at follow-up. The best correlation at both diagnosis and follow-up was seen in pancolitis (99% and 88%, respectively).
CONCLUSIONS: With regard to the extent of colonic involvement in the UC patients, we found less agreement between endoscopic and histological evaluation at the follow-up examination than at the start of the study. This could indicate that biopsies represent a better indicator than endoscopical examination for long term prognosis. Further studies are needed to confirm this finding.

Entities:  

Mesh:

Year:  1999        PMID: 10364026     DOI: 10.1111/j.1572-0241.1999.01145.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Ulcerative colitis extent varies with time but endoscopic appearances may be deceptive.

Authors:  J M Rhodes
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Colon capsule endoscopy: Advantages, limitations and expectations. Which novelties?

Authors:  Maria Elena Riccioni; Riccardo Urgesi; Rossella Cianci; Alessandra Bizzotto; Cristiano Spada; Guido Costamagna
Journal:  World J Gastrointest Endosc       Date:  2012-04-16

3.  Association of age at diagnosis and ulcerative colitis phenotype.

Authors:  Sandra M Quezada; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

Review 4.  Recent advances in understanding ulcerative colitis.

Authors:  Antonio Di Sabatino; Paolo Biancheri; Laura Rovedatti; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-11-09       Impact factor: 3.397

5.  Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.

Authors:  O Höie; L J Schouten; F L Wolters; I C Solberg; L Riis; I A Mouzas; P Politi; S Odes; E Langholz; M Vatn; R W Stockbrügger; B Moum
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

6.  Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.

Authors:  Qi-Kui Chen; Shi-Zheng Yuan; Zhuo-Fu Wen; Ying-Qiang Zhong; Cu-Jun Li; Hui-Sheng Wu; Can-Rong Mai; Peng-Yan Xie; Yu-Min Lu; Zhong-Lin Yu
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

Review 7.  Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies.

Authors:  Magnus Hofrenning Wanderås; Bjørn A Moum; Marte Lie Høivik; Øistein Hovde
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

8.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

9.  Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study.

Authors:  Mark H Flasar; Sandra Quezada; Priti Bijpuria; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2008-02-14       Impact factor: 3.199

Review 10.  History of and current issues affecting surgery for pediatric ulcerative colitis.

Authors:  Keiichi Uchida; Toshimitsu Araki; Masato Kusunoki
Journal:  Surg Today       Date:  2012-12-01       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.